Oncolytic Viruses for Canine Cancer Treatment
Oncolytic virotherapy has been investigated for several decades and is emerging as a plausible biological therapy with several ongoing clinical trials and two viruses are now approved for cancer treatment in humans. The direct cytotoxicity and immune-stimulatory effects make oncolytic viruses an int...
Main Authors: | Diana Sánchez, Gabriela Cesarman-Maus, Alfredo Amador-Molina, Marcela Lizano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/11/404 |
Similar Items
-
On the potential of oncolytic virotherapy for the treatment of canine cancers
by: MacNeill AL
Published: (2015-08-01) -
Oncolytic Virotherapy of Canine and Feline Cancer
by: Ivaylo Gentschev, et al.
Published: (2014-05-01) -
Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma
by: Amy L. MacNeill, et al.
Published: (2018-07-01) -
Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)
by: Galina V. Ilyinskaya, et al.
Published: (2018-06-01) -
Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma
by: King, Jamie N.
Published: (2019)